Kenji Arakawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kenji Arakawa has a total of 225 co-authors. Here are the top co-authors by number of shared publications:
Haruyasu Kinashi
Department of Molecular Biotechnology, Graduate School of Advanced Sciences of Matter, Hiroshima University, Hiroshima, Japan
16 shared publicationsAiko Teshima
Graduate School of Integrated Science for Life, Hiroshima University, Higashi-Hiroshima, Japan
14 shared publicationsKatsumi Kakinuma
Department of Chemistry, Tokyo Institute of Technology
12 shared publications- Tadashi Eguchi
Department of Chemistry, Tokyo Institute of Technology, 2-12-1 O-okayama, Meguro-ku, Tokyo 152-8551, Japan
11 shared publications Yosi Nindita
Program of Biotechnology, Graduate School of Integrated Sciences for Life, Hiroshima University, 1-3-1 Kagamiyama, Higashi-Hiroshima 739-8530, Japan; Hiroshima Research Center for Healthy Aging (HiHA), Hiroshima University, 1-3-1 Kagamiyama, Higashi-Hiroshima, Hiroshima 739-8530, Japan
9 shared publicationsAsahi Hirata
Graduate School of Integrated Science for Life, Hiroshima University, Higashi-Hiroshima, Japan
6 shared publications
Latest Publications
- Open Access
- 19 August 2026
- Published by Portland Press Ltd. in Essays in Biochemistry
- Vol. 70 (2) , 175-186
Distribution of lactone-signaling system for expression of secondary metabolite biosynthetic gene clusters in Streptomyces species
Many Streptomyces species have a signaling-molecule/receptor system for induction of secondary metabolite biosynthetic gene clusters (BGCs). Signaling molecules hitherto discovered and studied contain five-membered heterocycles, and are classified into three groups, including γ-butyrolactones, γ-butenolides, and furans. These molecules except for avenolide-type are biosynthesized by enzymes harboring an AfsA tandem repeat domain. These enzymes (AfsA homologs) catalyze a transfer of β-ketoacyl moiety to the hydroxyl group of dihydroxyacetone phosphate. Alignment of 59 afsA homolog genes showed that 86% (51/59) of them located adjacent to their possible signaling-molecule receptor genes, which reminds us to readily predict their signaling-molecule/receptor system for expression of BGCs. Apparent exception is the case of afsA-arpA system in Streptomyces griseus, whose distance was around 3.91 Mb. Understanding of the signaling-molecule/receptor system may lead to a practical genome mining strategy to awaken silent BGCs through derepression of transcription using the cognate ligands, signaling molecules.
- 19 August 2026
- Published by Portland Press Ltd. in Essays in Biochemistry
- Vol. 70 (2) , 175-186
Open AccessDistribution of lactone-signaling system for expression of secondary metabolite biosynthetic gene clusters in Streptomyces species
Many Streptomyces species have a signaling-molecule/receptor system for induction of secondary metabolite biosynthetic gene clusters (BGCs). Signaling molecules hitherto discovered and studied contain five-membered heterocycles, and are classified into three groups, including γ-butyrolactones, γ-butenolides, and furans. These molecules except for avenolide-type are biosynthesized by enzymes harboring an AfsA tandem repeat domain. These enzymes (AfsA homologs) catalyze a transfer of β-ketoacyl moiety to the hydroxyl group of dihydroxyacetone phosphate. Alignment of 59 afsA homolog genes showed that 86% (51/59) of them located adjacent to their possible signaling-molecule receptor genes, which reminds us to readily predict their signaling-molecule/receptor system for expression of BGCs. Apparent exception is the case of afsA-arpA system in Streptomyces griseus, whose distance was around 3.91 Mb. Understanding of the signaling-molecule/receptor system may lead to a practical genome mining strategy to awaken silent BGCs through derepression of transcription using the cognate ligands, signaling molecules.
- Open Access
- 9 June 2026
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 79 (8) , 1-10
Salt-induced 7-deoxypactamycin and oligomycin production in Streptomyces sp. strain TUA-HK1GM isolated from kusaya gravy
Streptomyces produce various antibiotics and bioactive compounds as secondary metabolites. Although they are normally found in soil, strains of Streptomyces have also been discovered in non-soil environments, including marine habitats. These non-terrestrial strains may have specific metabolic features compared with those of soil-dwelling Streptomyces . In this study, we investigated phenotypic and taxonomic characteristics, and antibiotic production of a Streptomyces sp. strain TUA-HK1GM that we previously isolated from kusaya gravy, a fermented fish gravy high in salt content. Microbiological analysis revealed distinct properties compared to closely related species, particularly in its ability to grow at 7% NaCl. Phylogenetic analysis suggested that strain TUA-HK1GM is a novel actinomycete species. We investigated the effects of NaCl supplementation on secondary metabolite biosynthesis, with a focus on antibiotic production. This strain produced antifungal compounds in the absence of NaCl, and these compounds were identified as oligomycins A and B. On the other hand, a large amount of anti- Staphylococcus compound was produced alongside oligomycin in the presence of NaCl. This compound had m/z values of 543.2813 [M + H]⁺ and 565.2633 [M+Na]⁺, which were consistent with those of 7-deoxypactamycin. Enhancement (32-fold) of oligomycin A production was also observed in a manner dependent on the duration of NaCl exposure. Supplementation with NaCl during cultivation demonstrated that prolonged exposure to NaCl increased the antibiotic production. These results indicate that the novel strain TUA-HK1GM has a characteristic mechanism that involves secondary metabolic activation by NaCl.
- 9 June 2026
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 79 (8) , 1-10
Open AccessSalt-induced 7-deoxypactamycin and oligomycin production in Streptomyces sp. strain TUA-HK1GM isolated from kusaya gravy
Streptomyces produce various antibiotics and bioactive compounds as secondary metabolites. Although they are normally found in soil, strains of Streptomyces have also been discovered in non-soil environments, including marine habitats. These non-terrestrial strains may have specific metabolic features compared with those of soil-dwelling Streptomyces . In this study, we investigated phenotypic and taxonomic characteristics, and antibiotic production of a Streptomyces sp. strain TUA-HK1GM that we previously isolated from kusaya gravy, a fermented fish gravy high in salt content. Microbiological analysis revealed distinct properties compared to closely related species, particularly in its ability to grow at 7% NaCl. Phylogenetic analysis suggested that strain TUA-HK1GM is a novel actinomycete species. We investigated the effects of NaCl supplementation on secondary metabolite biosynthesis, with a focus on antibiotic production. This strain produced antifungal compounds in the absence of NaCl, and these compounds were identified as oligomycins A and B. On the other hand, a large amount of anti- Staphylococcus compound was produced alongside oligomycin in the presence of NaCl. This compound had m/z values of 543.2813 [M + H]⁺ and 565.2633 [M+Na]⁺, which were consistent with those of 7-deoxypactamycin. Enhancement (32-fold) of oligomycin A production was also observed in a manner dependent on the duration of NaCl exposure. Supplementation with NaCl during cultivation demonstrated that prolonged exposure to NaCl increased the antibiotic production. These results indicate that the novel strain TUA-HK1GM has a characteristic mechanism that involves secondary metabolic activation by NaCl.
- Open Access
- 7 May 2026
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 79 (7) , 461-468
Discovery of actinomycin derivatives with improved selectivity against malaria parasites from a Streptomyces culture library
Our group explores the antimalarial compounds from the Streptomyces culture library. Pilot screening showed significant antimalarial activity in Streptomyces antibioticus HUT6035 (synonym of strain NBRC3117). We here isolated antimalarial compounds through large-scale fermentation and subsequent purification using chromatographies. Strain HUT6035 accumulated actinomycins X 2 and X 0ß , which were 4-oxo and 4-hydroxy proline derivatives of actinomycin D, respectively. The former showed an antimalaria activity (IC 50 = 0.241 nM) and a cytotoxicity (CC 50 = 6.71 nM), while the latter showed IC 50 = 7.69 nM and CC 50 = 818 nM. Compared with commercially available actinomycin D (IC 50 = 0.469 nM and CC 50 = 6.71 nM), both actinomycins X 2 and X 0ß have significant selectivity index (SI) values (CC 50 /IC 50 ) with 27.9 and 106. These SI values were two- and seven-fold preferential against that of actinomycin D (SI = 14.3). Thus, actinomycin derivatives are potential antimalarial agents.
- 7 May 2026
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 79 (7) , 461-468
Open AccessDiscovery of actinomycin derivatives with improved selectivity against malaria parasites from a Streptomyces culture library
Our group explores the antimalarial compounds from the Streptomyces culture library. Pilot screening showed significant antimalarial activity in Streptomyces antibioticus HUT6035 (synonym of strain NBRC3117). We here isolated antimalarial compounds through large-scale fermentation and subsequent purification using chromatographies. Strain HUT6035 accumulated actinomycins X 2 and X 0ß , which were 4-oxo and 4-hydroxy proline derivatives of actinomycin D, respectively. The former showed an antimalaria activity (IC 50 = 0.241 nM) and a cytotoxicity (CC 50 = 6.71 nM), while the latter showed IC 50 = 7.69 nM and CC 50 = 818 nM. Compared with commercially available actinomycin D (IC 50 = 0.469 nM and CC 50 = 6.71 nM), both actinomycins X 2 and X 0ß have significant selectivity index (SI) values (CC 50 /IC 50 ) with 27.9 and 106. These SI values were two- and seven-fold preferential against that of actinomycin D (SI = 14.3). Thus, actinomycin derivatives are potential antimalarial agents.
- 27 February 2026
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 141 (6) , 408-413
Occasional production by genome-wide deletion through removal of linear plasmid harboring tap-tpg gene pair in Streptomyces rochei
- 27 February 2026
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 141 (6) , 408-413
Occasional production by genome-wide deletion through removal of linear plasmid harboring tap-tpg gene pair in Streptomyces rochei
- Open Access
- 5 August 2025
- Published by Elsevier in The Microbe
- Vol. 8
Bioactivity screening and chemical profiling of Halymenia durvillei fermented by indigenous seaweed-associated Bacillus species
- 5 August 2025
- Published by Elsevier in The Microbe
- Vol. 8
Open AccessBioactivity screening and chemical profiling of Halymenia durvillei fermented by indigenous seaweed-associated Bacillus species
- Open Access
- 12 June 2025
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 78 (8) , 1-12
Rare distribution of butenolide-type signaling molecules among Streptomyces strains and functional importance as inducing factors for secondary metabolite production in Streptomyces rochei 7434AN4
Streptomyces rochei 7434AN4 produces two structurally unrelated polyketide antibiotics, lankacidin (LC) and lankamycin (LM), and their biosynthesis is tightly controlled by 2,3-disubstituted butenolide-type signaling molecules SRB1 and SRB2. We here investigated the distribution of 2,3-disubstituted butenolides (SRB-type butenolides) among randomly selected 122 Streptomyces strains using two approaches; (1) feeding of their culture extracts into an srrX-deficient strain KA20 of S. rochei, and (2) co-fermentation with strain KA20. All the randomly selected donor strains, except for Streptomyces cellostaticus (a LC and LM producer), failed to restore LC and LM production in strain KA20. These findings strongly revealed the rare distribution of SRB-type butenolide molecules in Streptomyces species. One of the SRB-type butenolide, SAB1, an inducing molecule for nikkomycin production in Streptomyces ansochromogenes, was unable to restore antibiotic production in strain KA20 even at 1 mM concentration. Furthermore, we noticed the accumulation of 4-dehydroxy-SRB1 as a novel compound when SRB1 was fed into strain KA20. Purified 4-dehydroxy-SRB1 has no inducing activity of antibiotic production in strain KA20 even at 1000-fold higher concentration (50 µM) against a minimum inducing concentration of natural SRB1 (40 nM). These findings suggested the importance of the length of a hydrocarbon chain attached at C-2 and a hydroxyl group at C-4 for inducing activity in S. rochei.
- 12 June 2025
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 78 (8) , 1-12
Open AccessRare distribution of butenolide-type signaling molecules among Streptomyces strains and functional importance as inducing factors for secondary metabolite production in Streptomyces rochei 7434AN4
Streptomyces rochei 7434AN4 produces two structurally unrelated polyketide antibiotics, lankacidin (LC) and lankamycin (LM), and their biosynthesis is tightly controlled by 2,3-disubstituted butenolide-type signaling molecules SRB1 and SRB2. We here investigated the distribution of 2,3-disubstituted butenolides (SRB-type butenolides) among randomly selected 122 Streptomyces strains using two approaches; (1) feeding of their culture extracts into an srrX-deficient strain KA20 of S. rochei, and (2) co-fermentation with strain KA20. All the randomly selected donor strains, except for Streptomyces cellostaticus (a LC and LM producer), failed to restore LC and LM production in strain KA20. These findings strongly revealed the rare distribution of SRB-type butenolide molecules in Streptomyces species. One of the SRB-type butenolide, SAB1, an inducing molecule for nikkomycin production in Streptomyces ansochromogenes, was unable to restore antibiotic production in strain KA20 even at 1 mM concentration. Furthermore, we noticed the accumulation of 4-dehydroxy-SRB1 as a novel compound when SRB1 was fed into strain KA20. Purified 4-dehydroxy-SRB1 has no inducing activity of antibiotic production in strain KA20 even at 1000-fold higher concentration (50 µM) against a minimum inducing concentration of natural SRB1 (40 nM). These findings suggested the importance of the length of a hydrocarbon chain attached at C-2 and a hydroxyl group at C-4 for inducing activity in S. rochei.
- 10 May 2025
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 140 (1) , 36-41
Date, a major dried fruit, extends the lifespan of Caenorhabditis elegans
- 10 May 2025
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 140 (1) , 36-41
Date, a major dried fruit, extends the lifespan of Caenorhabditis elegans
- Open Access
- 12 November 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (21) , e70150
A unique compound ameliorating endoplasmic reticulum stress and insulin resistance by binding to β tubulin
Insulin is secreted by the pancreatic β‐cells and regulates glucose uptake. Endoplasmic reticulum (ER) stress is known to induce insulin resistance. Identifying novel compounds, which can ameliorate ER stress and insulin resistance may be beneficial in the treatment of diabetes. Since treatment with compounds sourced from edible plants is relatively safe, this study aimed to identify a plant‐derived potential compound attenuating insulin resistance. In the present study, we identified apigenin as an effective compound for ameliorating ER stress and insulin resistance. It attenuated ER stress‐induced cell death and hepatic insulin resistance and improved abnormal glucose tolerance in a db/db diabetic model. The molecular mechanism of apigenin involved direct binding to β‐tubulin and improving tubulin stability, thereby recovering insulin resistance and developing diabetes. To our knowledge, no known antidiabetic drugs are yet known to target β‐tubulin. Edible plants containing apigenins, such as onions, oranges, and parsley, have been consumed since a long time. Therefore, the use of natural edible plants as a source may offer a safe strategy for the prevention of diabetes.
- 12 November 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (21) , e70150
Open AccessA unique compound ameliorating endoplasmic reticulum stress and insulin resistance by binding to β tubulin
Insulin is secreted by the pancreatic β‐cells and regulates glucose uptake. Endoplasmic reticulum (ER) stress is known to induce insulin resistance. Identifying novel compounds, which can ameliorate ER stress and insulin resistance may be beneficial in the treatment of diabetes. Since treatment with compounds sourced from edible plants is relatively safe, this study aimed to identify a plant‐derived potential compound attenuating insulin resistance. In the present study, we identified apigenin as an effective compound for ameliorating ER stress and insulin resistance. It attenuated ER stress‐induced cell death and hepatic insulin resistance and improved abnormal glucose tolerance in a db/db diabetic model. The molecular mechanism of apigenin involved direct binding to β‐tubulin and improving tubulin stability, thereby recovering insulin resistance and developing diabetes. To our knowledge, no known antidiabetic drugs are yet known to target β‐tubulin. Edible plants containing apigenins, such as onions, oranges, and parsley, have been consumed since a long time. Therefore, the use of natural edible plants as a source may offer a safe strategy for the prevention of diabetes.
- Open Access
- 9 July 2024
- Published by Springer Nature in Tropical Medicine and Health
- Vol. 52 (1) , 1-11
Discovery of antimalarial drugs from secondary metabolites in actinomycetes culture library
Background: Natural products play a key role as potential sources of biologically active substances for the discovery of new drugs. This study aimed to identify secondary metabolites from actinomycete library extracts that are potent against the asexual stages of Plasmodiumfalciparum (P.falciparum). Methods: Secondary metabolites from actinomycete library extracts were isolated from culture supernatants by ethyl acetate extraction. Comprehensive screening was performed to identify novel antimalarial compounds from the actinomycete library extracts (n = 28). The antimalarial activity was initially evaluated in vitro against chloroquine/mefloquine-sensitive (3D7) and-resistant (Dd2) lines of P.falciparum. The cytotoxicity was then evaluated in primary adult mouse brain (AMB) cells. Results: Out of the 28 actinomycete extracts, 17 showed parasite growth inhibition > 50% at a concentration of 50 µg/mL, nine were identified with an IC50 value < 10 µg/mL, and seven suppressed the parasite significantly with an IC50 value < 5 µg/mL. The extracts from Streptomycesaureus strains HUT6003 (Extract ID number: 2), S.antibioticus HUT6035 (8), and Streptomyces sp. strains GK3 (26) and GK7 (27), were found to have the most potent antimalarial activity with IC50 values of 0.39, 0.09, 0.97, and 0.36 µg/mL (against 3D7), and 0.26, 0.22, 0.72, and 0.21 µg/mL (against Dd2), respectively. Among them, Streptomycesantibioticus strain HUT6035 (8) showed the highest antimalarial activity with an IC50 value of 0.09 µg/mL against 3D7 and 0.22 µg/mL against Dd2, and a selective index (SI) of 188 and 73.7, respectively. Conclusion: Secondary metabolites obtained from the actinomycete extracts showed promising antimalarial activity in vitro against 3D7 and Dd2 cell lines of P.falciparum with minimal toxicity. Therefore, secondary metabolites obtained from actinomycete extracts represent an excellent starting point for the development of antimalarial drug leads.
- 9 July 2024
- Published by Springer Nature in Tropical Medicine and Health
- Vol. 52 (1) , 1-11
Open AccessDiscovery of antimalarial drugs from secondary metabolites in actinomycetes culture library
Background: Natural products play a key role as potential sources of biologically active substances for the discovery of new drugs. This study aimed to identify secondary metabolites from actinomycete library extracts that are potent against the asexual stages of Plasmodiumfalciparum (P.falciparum). Methods: Secondary metabolites from actinomycete library extracts were isolated from culture supernatants by ethyl acetate extraction. Comprehensive screening was performed to identify novel antimalarial compounds from the actinomycete library extracts (n = 28). The antimalarial activity was initially evaluated in vitro against chloroquine/mefloquine-sensitive (3D7) and-resistant (Dd2) lines of P.falciparum. The cytotoxicity was then evaluated in primary adult mouse brain (AMB) cells. Results: Out of the 28 actinomycete extracts, 17 showed parasite growth inhibition > 50% at a concentration of 50 µg/mL, nine were identified with an IC50 value < 10 µg/mL, and seven suppressed the parasite significantly with an IC50 value < 5 µg/mL. The extracts from Streptomycesaureus strains HUT6003 (Extract ID number: 2), S.antibioticus HUT6035 (8), and Streptomyces sp. strains GK3 (26) and GK7 (27), were found to have the most potent antimalarial activity with IC50 values of 0.39, 0.09, 0.97, and 0.36 µg/mL (against 3D7), and 0.26, 0.22, 0.72, and 0.21 µg/mL (against Dd2), respectively. Among them, Streptomycesantibioticus strain HUT6035 (8) showed the highest antimalarial activity with an IC50 value of 0.09 µg/mL against 3D7 and 0.22 µg/mL against Dd2, and a selective index (SI) of 188 and 73.7, respectively. Conclusion: Secondary metabolites obtained from the actinomycete extracts showed promising antimalarial activity in vitro against 3D7 and Dd2 cell lines of P.falciparum with minimal toxicity. Therefore, secondary metabolites obtained from actinomycete extracts represent an excellent starting point for the development of antimalarial drug leads.